[go: up one dir, main page]

DK1446478T3 - Dimeriseret vækstfaktor samt materialer og fremgangmåder til fremstilling heraf - Google Patents

Dimeriseret vækstfaktor samt materialer og fremgangmåder til fremstilling heraf

Info

Publication number
DK1446478T3
DK1446478T3 DK02773824T DK02773824T DK1446478T3 DK 1446478 T3 DK1446478 T3 DK 1446478T3 DK 02773824 T DK02773824 T DK 02773824T DK 02773824 T DK02773824 T DK 02773824T DK 1446478 T3 DK1446478 T3 DK 1446478T3
Authority
DK
Denmark
Prior art keywords
sub
polypeptide chains
amino acid
making
materials
Prior art date
Application number
DK02773824T
Other languages
Danish (da)
English (en)
Inventor
Margaret D Moore
Brian A Fox
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK1446478T3 publication Critical patent/DK1446478T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/49Platelet-derived growth factor [PDGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Glass Compositions (AREA)
DK02773824T 2001-10-19 2002-10-18 Dimeriseret vækstfaktor samt materialer og fremgangmåder til fremstilling heraf DK1446478T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34611701P 2001-10-19 2001-10-19
PCT/US2002/033563 WO2003033677A2 (fr) 2001-10-19 2002-10-18 Facteur de croissance dimerise et materiaux et procedes utilises pour sa production

Publications (1)

Publication Number Publication Date
DK1446478T3 true DK1446478T3 (da) 2008-06-02

Family

ID=23358033

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02773824T DK1446478T3 (da) 2001-10-19 2002-10-18 Dimeriseret vækstfaktor samt materialer og fremgangmåder til fremstilling heraf

Country Status (10)

Country Link
US (1) US7122351B2 (fr)
EP (1) EP1446478B1 (fr)
JP (1) JP2005506073A (fr)
AT (1) ATE384783T1 (fr)
AU (1) AU2002337920A1 (fr)
CA (1) CA2463003A1 (fr)
DE (1) DE60224822T2 (fr)
DK (1) DK1446478T3 (fr)
ES (1) ES2302845T3 (fr)
WO (1) WO2003033677A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287850B1 (en) * 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
PT1234031T (pt) 1999-11-30 2017-06-26 Mayo Foundation B7-h1, uma nova molécula imunoregulatória
US7030219B2 (en) 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
AU2003210996A1 (en) * 2002-02-11 2003-09-04 Zymogenetics, Inc. Materials and methods for preparing dimeric growth factors
US7432351B1 (en) 2002-10-04 2008-10-07 Mayo Foundation For Medical Education And Research B7-H1 variants
AR046594A1 (es) * 2003-10-16 2005-12-14 Applied Research Systems Usos terapeuticos de variantes de quemoquina
US7381794B2 (en) 2004-03-08 2008-06-03 Zymogenetics, Inc. Dimeric fusion proteins and materials and methods for producing them
PT3428191T (pt) 2004-10-06 2024-12-30 Mayo Found Medical Education & Res B7-h1 e tratamento do carcinona de células renais
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
WO2007061889A2 (fr) 2005-11-17 2007-05-31 Biomimetic Therapeutics, Inc. Augmentation osseuse maxillo-faciale au moyen de rhpdgf-bb et d'une matrice biocompatible
EP1801121A1 (fr) * 2005-12-23 2007-06-27 CONARIS research institute AG Variantes solubles de la molécule gp130 utiles comme médicament
ES2427993T3 (es) * 2006-02-09 2013-11-05 Biomimetic Therapeutics, Llc Composiciones y métodos para el tratamiento de hueso
US9161967B2 (en) * 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
WO2008005427A2 (fr) * 2006-06-30 2008-01-10 Biomimetic Therapeutics, Inc. Compositions et procédés destinés au traitement de lésions de la coiffe des rotateurs
EP2462895B1 (fr) 2006-11-03 2016-11-02 BioMimetic Therapeutics, LLC Compositions et procédé pour des procédures arthrodétiques
EP2514762B1 (fr) 2007-07-13 2015-04-08 The Johns Hopkins University Variants de B7-DC
EP2268301B1 (fr) * 2008-01-24 2020-02-26 Remedor Biomed Ltd. Compositions d'érythropoiétine et de fibronectine pour la régénération osseuse
CA2715254A1 (fr) * 2008-02-07 2009-08-13 Biomimetic Therapeutics, Inc. Compositions et procedes associes a une osteogenese par distraction
EP2927240A1 (fr) 2008-08-25 2015-10-07 Amplimmune, Inc. Compositions d'antagonistes pd-1 et procédés d'utilisation
CN102231992B (zh) 2008-09-09 2015-05-20 生物模拟治疗公司 用于治疗肌腱和韧带损伤的血小板衍生生长因子的组合物和方法
JP2012519556A (ja) * 2009-03-05 2012-08-30 バイオミメティック セラピューティクス, インコーポレイテッド 骨軟骨欠損を治療するための血小板由来増殖因子組成物および方法
BR112012020566B1 (pt) 2010-02-22 2021-09-21 Biomimetic Therapeutics, Llc Composição de fator de crescimento derivado de plaqueta
US9133486B2 (en) * 2012-03-12 2015-09-15 The Board Of Trustees Of The Leland Stanford Junior University Hydrogenase fusion protein for improved hydrogen production
RU2014143639A (ru) 2012-03-30 2016-05-27 Байер Хелскеа Ллк Регулируемые протеазой антитела
US9302005B2 (en) 2013-03-14 2016-04-05 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
US10259875B2 (en) 2013-10-01 2019-04-16 Mayo Foundation For Medical Education And Research Methods for treating cancer in patients with elevated levels of BIM
WO2015179654A1 (fr) 2014-05-22 2015-11-26 Mayo Foundation For Medical Education And Research Distinction d'anticorps anti-b7-h1 agonistes et antagonistes
US10517875B2 (en) 2014-07-23 2019-12-31 Mayo Foundation for Medical Engineering and Research Targeting DNA-PKcs and B7-H1 to treat cancer
US10875923B2 (en) 2015-10-30 2020-12-29 Mayo Foundation For Medical Education And Research Antibodies to B7-H1
WO2020092839A1 (fr) 2018-10-31 2020-05-07 Mayo Foundation For Medical Education And Research Méthodes et matériaux de traitement du cancer
EP3873540A4 (fr) 2018-10-31 2022-07-27 Mayo Foundation for Medical Education and Research Procédés et matériaux pour le traitement du cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013653A (en) * 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
US6018026A (en) * 1988-01-22 2000-01-25 Zymogenetics, Inc. Biologically active dimerized and multimerized polypeptide fusions
ATE140963T1 (de) * 1988-01-22 1996-08-15 Zymogenetics Inc Verfahren zur herstellung von sekretierten rezeptoranalogen
EP0452364B1 (fr) 1988-12-22 2002-05-22 Genentech, Inc. Procede de preparation de polypeptides solubles dans l'eau
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
WO1995021258A1 (fr) * 1994-02-01 1995-08-10 United States Of America, Represented By The Secretary, Department Of Health And Human Services Proteines de fusion comprenant des parties anticorpales et non anticorpales
US5731168A (en) * 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
GB9720054D0 (en) * 1997-09-19 1997-11-19 Celltech Therapeutics Ltd Biological products
EP2151454B1 (fr) * 1998-11-10 2012-05-02 Ludwig Institute For Cancer Research Facteur de croissance D dérivés de plaquettes tronquée, l'ADN codant pour celui-ci et ses utilisations
US6468543B1 (en) * 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
EP1686134A3 (fr) 1999-12-01 2006-08-09 Genentech, Inc. Polypeptides transmembranaires et secrétés et les acides nucléiques codant ceux-ci
EP1254242A4 (fr) 2000-01-31 2005-02-23 Human Genome Sciences Inc 17 proteines secretees humaines
AU2001270609A1 (en) 2000-06-30 2002-01-14 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Heterodimeric fusion proteins
AU2002245652A1 (en) 2001-03-09 2002-09-24 Zymogenetics, Inc. Soluble heterodimeric cytokine receptor

Also Published As

Publication number Publication date
EP1446478B1 (fr) 2008-01-23
US7122351B2 (en) 2006-10-17
ATE384783T1 (de) 2008-02-15
WO2003033677A3 (fr) 2003-07-10
WO2003033677A2 (fr) 2003-04-24
JP2005506073A (ja) 2005-03-03
US20030109000A1 (en) 2003-06-12
DE60224822T2 (de) 2009-01-22
DE60224822D1 (de) 2008-03-13
CA2463003A1 (fr) 2003-04-24
ES2302845T3 (es) 2008-08-01
EP1446478A4 (fr) 2005-03-16
EP1446478A2 (fr) 2004-08-18
AU2002337920A1 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
DK1446478T3 (da) Dimeriseret vækstfaktor samt materialer og fremgangmåder til fremstilling heraf
FI2784084T4 (fi) Antagonistivasta-aineet IL-17A/F heterologisille polypeptideille
Isaacs Cystine knots
EE05539B1 (et) Hbriidvalk, selle kasutamine, seda sisaldav antikeha v?i selle fragment ja selle kasutamine
DE69412614D1 (de) Recombinante disulfid-stabilisierte polypeptide mit bindung spezifität
Mann et al. Characterization of proteolytic fragments of the laminin‐nidogen complex and their activity in ligand‐binding assays
Kurucz et al. Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies
CA2318482A1 (fr) Recepteurs de l'interleukine-18
HRP20150444T1 (hr) Trovalentna, bispecifiäśna protutijela
AU5510286A (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
EP1392359A4 (fr) Proteines de liaison specifiques et utilisations associees
WO2000023565B1 (fr) Nouvelle liaison neuropiline/facteur de croissance et applications de celle-ci
DE602005026072D1 (de) Ligand für den formylpeptidrezeptorähnlichen-2 (FPRL2) G Protein gekoppelten Rezeptor
FR2736916B1 (fr) Proteines hetero-multimeriques recombinantes du type alpha-beta c4bp
WO2003014160A3 (fr) Variants de cd44 comportant des chaines d'heparane sulfate et leurs utilisations
CA2519993A1 (fr) Agregation de polypeptides dependante du ph et son utilisation
Violand et al. A novel concatenated dimer of recombinant bovine somatotropin
WO2003031590A3 (fr) Acides nucleiques codant des domaines chromo/fluorescents relies et leurs procedes d'utilisation
ATE317851T1 (de) Polypeptide mit aminosäuresequenzen aus dem n- terminalen bereich von gp116 von cytomegalovirus und deren verwendung bei der diagnostik, prophylaxe und therapie
Sturm Peptide-protein interactive model systems: Studies on the binding of curarimimetic neurotoxins and interleukin-1-beta to their receptors.
Beale et al. The sites of tryptic cleavage in bovine secretory component: structural and functional implications
EA199900663A1 (ru) Новые белки, связывающиеся с рецептором 1 интерферона, кодирующая их днк и способы модуляции клеточного ответа на интерфероны
WO2004005489A3 (fr) Acides nucleiques codant l'antigene sarcosystis neurona et leurs utilisations